0001974158-24-000024.txt : 20240411
0001974158-24-000024.hdr.sgml : 20240411
20240411163232
ACCESSION NUMBER: 0001974158-24-000024
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20240411
DATE AS OF CHANGE: 20240411
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Enliven Therapeutics, Inc.
CENTRAL INDEX KEY: 0001672619
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 811523849
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-39247
FILM NUMBER: 24838903
BUSINESS ADDRESS:
STREET 1: 6200 LOOKOUT ROAD
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 720-647-8519
MAIL ADDRESS:
STREET 1: 6200 LOOKOUT ROAD
CITY: BOULDER
STATE: CO
ZIP: 80301
FORMER COMPANY:
FORMER CONFORMED NAME: IMARA Inc.
DATE OF NAME CHANGE: 20160419
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Heyman Richard A.
CENTRAL INDEX KEY: 0001584759
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: 5871 OBERLIN DRIVE, SUITE 150
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
144
1
primary_doc.xml
144
0001584759
XXXXXXXX
LIVE
0001672619
Enliven Therapeutics, Inc.
001-39247
6200 LOOKOUT ROAD
BOULDER
CO
80301
720-647-8519
Heyman Richard A.
Director
Common
Jefferies LLC
520 Madison Ave, 4th Fl
New York
NY
10022
6315
125163.30
41000000
04/11/2024
Nasdaq
Common
01/19/2022
Exercised Stock Options
Enliven Therapeutics, Inc
N
6315
01/19/2022
N/A
N
Richard Heyman
6200 Lookout Road, 1st FL
Boulder
CO
80301
Enliven Therapeutics
03/19/2024
1270
18418.66
Richard Heyman
6200 Lookout Road, 1st FL
Boulder
CO
80301
Enliven Therapeutics
02/15/2024
1270
22117.38
Richard Heyman
6200 Lookout Road, 1st FL
Boulder
CO
80301
Enliven Therapeutics
01/30/2024
1270
20839.51
All Sales are to be made pursuant to a previously signed/adopted 10b5-1 Selling plan dated 07/17/2023, and all
representations regarding material non-public information were made as of the adoption of the plan.
04/11/2024
07/17/2023
Richard Heyman